Nasal inflammation, nasal polyps and rhinitis
Important safety information
The CSM recommends that when children are receiving prolonged treatment with nasal corticosteroids the height of the child should be monitored. If growth is slowed than paediatric referral should be considered. They are not licensed for use in young children.
Beclometasone nasal spray, available as a generic, is considered as first line therapy. It is relatively cheap, effective and well tolerated, requiring twice daily administration.
Beclometasone is licensed for the prophylaxis and treatment of allergic and vasomator rhinitis. Fluticasone is only licensed for the prophylaxis and treatment of allergic rhinitis.
Fluticasone furoate has a novel device which some adults and children may find easier to use.
Betamethasone nose drops are licensed for non-infected inflammatory conditions of the ear or nose.
For seasonal rhinitis, prophylaxis should begin one week before the start of the pollen season and continue throughout.
Systemic absorption may follow on from any nasal steroid particularly if the doses are high and prolonged.
For the general actions, warnings and prescribing notes for steroids, see Corticosteroid responsive conditions
Some brands are available over the counter
Licensed in patients over 12 years of age for the treatment of moderate to severe seasonal and perennial allergic rhinitis, if monotherapy with antihistamine or corticosteroid is inadequate